Hideki Obara, Yota Tatara, Satoru Monzen, Sho Murakami, Hiroki Yamamoto, Naoki Kimura, Masashi Suzuki, Fumio Komai, Masataka Narita, Yoshiomi Hatayama, et al. Exploring predictive molecules of acute adverse events in response to volumetric-modulated arc therapy for prostate cancer using urinary metabolites. Molecular and clinical oncology. 2024. 21. 3. 62-62
Yoshiomi Hatayama, Shiori Kudo, Riko Ota, Akane Kuroki, Mitsuki Tanaka, Chihiro Yotsuya, Koji Ichise, Ichitaro Fujioka, Mariko Sato, Hideo Kawaguchi, et al. Investigation of the efficacy of the change ratio of brain natriuretic peptide for predicting the cardiac effects of chemoradiotherapy on esophageal cancer. Oncology letters. 2023. 26. 4. 439-439
Daichi Sasaki, Shingo Hatakeyama, Hideo Kawaguchi, Yoshiomi Hatayama, Yusuke Ishibashi, Ayumu Kusaka, Daisuke Noro, Toshikazu Tanaka, Hiroyuki Ito, Yoshiharu Okuyama, et al. Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study. Urologic oncology. 2022. 40. 2. 64.e1-64.e8
Mitsuki Tanaka, Ichise Koji, Ichitaro Fujioka, Mariko Sato, Katsumi Hirose, Hideo Kawaguchi, Yoshiomi Hatayama, Yoshihiro Takai, Eiki Tsushima, Masahiko Aoki. Impact of low iodine density tumor area ratio on the local control of non-small cell lung cancer through stereotactic body radiotherapy. Journal of radiation research. 2021. 62. 3. 448-456
